Skip to main content
72°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
December 17, 2024
Tickers
BAYRY
NEWS
REGN
Tags
why it's moving
General
Benzinga
From
Benzinga
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
December 17, 2024
Tickers
APA
ASML
AVGO
CEG
Tags
CEG
Top Stories
Retail Sales
From
Benzinga
What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
December 17, 2024
Tickers
REGN
Tags
Analyst Ratings
Market News
BZI/AAR
From
Benzinga
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
December 04, 2024
Tickers
LB
LLY
NEWS
NVTS
Tags
mad money Lightning Round
LB
SNY
From
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
November 26, 2024
Tickers
REGN
Tags
BZI/UOA
REGN
Benzinga
From
Benzinga
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking
November 19, 2024
Tickers
REGN
Tags
Benzinga
REGN
BZI/UOA
From
Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
November 18, 2024
Tickers
REGN
Tags
BZI/SHORTHIST
Market News
Trading Ideas
From
Benzinga
Check Out What Whales Are Doing With REGN
November 15, 2024
Tickers
REGN
Tags
Benzinga
REGN
BZI/UOA
From
Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
November 15, 2024
Tickers
NEWS
REGN
SNY
Tags
General
Top Stories
Benzinga
From
Benzinga
28 Analysts Have This To Say About Regeneron Pharmaceuticals
November 14, 2024
Tickers
REGN
Tags
REGN
Benzinga
Analyst Ratings
From
Benzinga
2 Top Growth Stocks to Buy on the Dip
November 14, 2024
Tickers
LLY
REGN
Tags
Market News
Recent Press Releases
LLY
From
Motley Fool
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
November 13, 2024
Tickers
AZN
GSK
NEWS
REGN
Tags
Market News
Briefs
SNY
From
Benzinga
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
November 06, 2024
Tickers
NEWS
REGN
Tags
Market News
Markets
BZI/IA
From
Benzinga
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
November 06, 2024
Tickers
ASML
DELL
IDXX
MRNA
Tags
SMCI
Recent Press Releases
DELL
From
Motley Fool
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
November 05, 2024
Tickers
AMGN
AZN
NEWS
REGN
Tags
SNY
News
Trading Ideas
From
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
November 04, 2024
Tickers
REGN
Tags
Markets
Options
Market News
From
Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
Tickers
NEWS
NVO
REGN
SNY
Tags
Earnings
Stories That Matter
Biotech
From
Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
October 31, 2024
Tickers
AAPL
AMGN
AMZN
BKNG
Tags
CTRA
AAPL
Pro Project
From
Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
Tickers
ABBV
AMGN
BIIB
BMY
Tags
General
Analyst Ratings
BIIB
From
Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
October 28, 2024
Tickers
EYPT
NEWS
REGN
Tags
Stories That Matter
Biotech
General
From
Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
October 28, 2024
Tickers
AMGN
CMG
GS
LLY
Tags
WMT
GS
Recent Press Releases
From
Motley Fool
Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
October 25, 2024
Tickers
LLY
NEWS
REGN
SNY
Tags
Biotech
Stories That Matter
Benzinga
From
Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $5,800 Today
October 24, 2024
Tickers
NEWS
REGN
Tags
Trading Ideas
News
REGN
From
Benzinga
A Closer Look at 23 Analyst Recommendations For Regeneron Pharmaceuticals
October 23, 2024
Tickers
REGN
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Exploring The Competitive Space: Regeneron Pharmaceuticals Versus Industry Peers In Biotechnology
October 23, 2024
Tickers
NEWS
REGN
Tags
News
Trading Ideas
REGN
From
Benzinga
Seagate To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Wednesday
October 23, 2024
Tickers
MCD
MCO
NEWS
NSC
Tags
ZION
Market News
PT Changes
From
Benzinga
Market Whales and Their Recent Bets on REGN Options
October 23, 2024
Tickers
REGN
Tags
REGN
Benzinga
BZI/UOA
From
Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth Today
October 10, 2024
Tickers
NEWS
REGN
Tags
BZI/POD
Market News
REGN
From
Benzinga
What the Options Market Tells Us About Regeneron Pharmaceuticals
October 10, 2024
Tickers
REGN
Tags
Market News
Options
Markets
From
Benzinga
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
October 09, 2024
Tickers
AMGN
AZN
BMRN
GILD
Tags
General
Benzinga
Top Stories
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.